Related Content
![Three doctors in white lab coats against a pink background Three doctors in white lab coats against a pink background](/sites/default/files/us/2023-05/Article%20-%20Press%20Release%20teaser%20cards.jpeg)
Pulmonary Fibrosis
FIBRONEER™ trials for IPF, other progressive fibrosing ILDs
Donald Zoz, M.D., Director and Senior Clinical Program Leader for Pulmonary Fibrosis at Boehringer Ingelheim, discusses the unmet needs of patients with IPF and other forms of progressive fibrosing ILDs and the FIBRONEER™ global clinical program
Read more
Related Press Release
![New global guidelines for progressive pulmonary fibrosis now available New global guidelines for progressive pulmonary fibrosis now available](/sites/default/files/us/2023-01/Guidelines-PPF_0.png)
May 03, 2022
Boehringer Ingelheim Statement on Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
![White graphic illustration of lungs White graphic illustration of lungs](/sites/default/files/us/2023-01/BI-1015550_breakthrough.png)
February 24, 2022